During cardiopulmonary resuscitation, the same dosage may be given via the intraosseous route when IV access is unsuccessful or not feasible. NOTE: Lidocaine is not FDA-approved for intraosseous administration. Multiple administrations at the same location are not recommended. Lidocaine is delivered to the dermis by a needle-free, helium-pressurized delivery system. A popping sound like a burst balloon is heard when the device is actuated.
#Lidocaine swish and swallow skin
Pressing the device against the skin will release the safety interlock. Ensure an adequate seal between the device and the skin. Press the device against an intact area of skin. Do not use around the eyes, on body orifices, on mucous membranes, or on areas with a compromised skin barrier. Only use on skin locations where an adequate seal can be maintained. Each device contains 0.5 mg of sterile lidocaine hydrochloride monohydrate powder. Use an infusion pump to administer by continuous infusion. The maximum concentration for continuous IV infusion is 8 mg/mL. ASHP Recommended Standard Concentrations for Pediatric Continuous Infusions: 4 mg/mL or 8 mg/mL. Non-CPR indications: Administer bolus injection at a rate of 0.35 to 0.7 mg/kg/minute (25 to 50 mg/minute). During cardiopulmonary resuscitation (CPR): Administer IV push. Monitor blood pressure and ECG during IV administration. Visually inspect parenteral products for particulate matter and discoloration prior to administration whenever solution and container permit. For storage information, see the specific product information within the How Supplied section.
0 kommentar(er)
